These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Low doses of acetylsalicylic acid effectively inhibits thrombocyte aggregation after ischemic stroke]. Oláh L; Misz M; Bereczki D; Fekete I; Bordánné JE; Takács EI Orv Hetil; 1996 Mar; 137(9):455-9. PubMed ID: 8714038 [TBL] [Abstract][Full Text] [Related]
23. The mechanism of anti-platelet activity of davallialactone: involvement of intracellular calcium ions, extracellular signal-regulated kinase 2 and p38 mitogen-activated protein kinase. Kim SD; Lee IK; Lee WM; Cho JY; Park HJ; Oh JW; Park SC; Kim SK; Kwak YS; Yun BS; Rhee MH Eur J Pharmacol; 2008 Apr; 584(2-3):361-7. PubMed ID: 18313047 [TBL] [Abstract][Full Text] [Related]
24. Impairment of platelet behaviour by isosorbide dinitrate. Dutrillaux F; Lecompte T; Samama M Thromb Haemost; 1989 Feb; 61(1):152-3. PubMed ID: 2665166 [No Abstract] [Full Text] [Related]
25. [The effect of melatonin on thrombocyte aggregation in healthy subjects]. Evsiukova EV; Petrishchev NN Fiziol Cheloveka; 1998; 24(6):122-5. PubMed ID: 9929964 [No Abstract] [Full Text] [Related]
26. A comparison of the effects of cisplatin and cisplatinum (II)phosphonate complex on ADP-induced platelet aggregation in vitro. Kostka B; Ochocki J Pharmazie; 1996 Dec; 51(12):990-2. PubMed ID: 8985988 [No Abstract] [Full Text] [Related]
27. Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins. Di Braccio M; Grossi G; Roma G; Grazia Signorello M; Leoncini G Eur J Med Chem; 2004 May; 39(5):397-409. PubMed ID: 15110966 [TBL] [Abstract][Full Text] [Related]
28. Non-specific inhibition of ADP-induced platelet antiaggregation by clopidogrel in vitro. Herbert JM; Savi P Thromb Haemost; 1999 Jul; 82(1):156-7. PubMed ID: 10456476 [No Abstract] [Full Text] [Related]
37. [The effect of new synthetic prostanoids on the aggregation activity of human thrombocytes]. Petrukhina GN; Makarova VA; FReĭmanis IaF; Lozha EV Eksp Klin Farmakol; 1995; 58(6):45-8. PubMed ID: 8704613 [TBL] [Abstract][Full Text] [Related]
38. [Difference in inhibitory actions of products of the myeloperoxidase- catalyzed reaction on initial aggregation of activated platelets]. Rpshchupkin DI; Berzhitskaia VV; Murina MA Biofizika; 1998; 43(2):323-8. PubMed ID: 9591107 [TBL] [Abstract][Full Text] [Related]